FDA Clears Syneron's New Fast ST Applicator for Non-Invasive Treatment of Wrinkles
Thursday March 16, 9:21 am ET
Using New Applicator With Syneron's New eLight(TM) and eMax(TM) Platforms, Physicians Can Achieve Tightening of Skin via Wrinkle Reduction With the Fastest Treatment Time on the Market
YOKNEAM, ISRAEL and TORONTO--(MARKET WIRE)--Mar 16, 2006 -- Syneron Medical Ltd. (NasdaqNM:ELOS - News) today announced that the US Food & Drug Administration (FDA) granted a 510(k) marketing clearance to Syneron's new ST applicator for non-invasive wrinkle treatment. Using the ST applicator, the ReFirme(TM) procedure offers a non-invasive, less painful alternative for patients wanting to achieve skin tightening and improvement in skin laxity through wrinkle reduction on the neck, face, and other areas of the body. With a pulse repetition rate of one pulse per second, and using Syneron's elôs(TM) technology, the ReFirme treatment with the ST applicator is by far the fastest and most effective on the market.